Live Chart

O 788

H 788

L 788

VOL 1644

Glenmark Pharmaceuticals Overview

Days Range

Low: ₹760.20
High: ₹789.45
Previous Close ₹785.55
Open ₹788.00
Volume 12,41,742
Day’s Range ₹760.20 - ₹789.45
52W Range ₹363.65 - ₹880.00
Market Cap ₹22,175 Cr

Fundamentals of Glenmark Pharmaceuticals

ROCE (TTM) 13.68%
P/E Ratio (TTM) 87.13
P/B Ratio 2.34
Industry P/E 31.67
Debt to Equity 0.49
ROE 5.94%
EPS (TTM) 31.66
Dividend Yield 0.32%
Book Value 336
Face Value 1

Financials of Glenmark Pharmaceuticals

Sep 2022Dec 2022Mar 2023Jun 2023
Net Sales3,375.253,463.863,373.723,401.6
Profit before tax480.21471-490.77333.41
Operating Profit278.67290.76-403.14173.13
Net Profit278.67290.76-403.14173.13
EPS in Rs9.238.5314.936.91

About Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977. The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity ... Read More

Parent Organisation Indian Private
Founded 1977
Managing Director Glenn Saldanha

Peer Comparison

Stocks Market Cap (cr) Market Price (₹) 52 Week Low-High (₹)
Torrent Pharmaceuticals Ltd ₹62,519.33


14.55 (-0.79%)

1821.45 - 1849.95
Lupin Ltd ₹50,548.79


0.00 (0.00)

1105.35 - 1118.6
Gland Pharma Ltd ₹27,334.57


29.10 (-1.75%)

1623 - 1700
Syngene International Ltd ₹30,945.10


1.35 (-0.18%)

763.05 - 774
Alkem Laboratories Ltd ₹42,468.29


25.55 (-0.72%)

3523.05 - 3564.9

What's Trending


What is the Share price of Glenmark Pharmaceuticals (GLENMARK)?

Glenmark Pharmaceuticals (GLENMARK) share price as of September 26, 2023, on NSE is Rs 762.25 (NSE) and Rs 762.55 (BSE) on BSE.

Can I buy Glenmark Pharmaceuticals (GLENMARK) shares?

Yes, You can buy Glenmark Pharmaceuticals (GLENMARK) shares by opening a Demat account with Angel One.

How do I buy Glenmark Pharmaceuticals (GLENMARK) from Angel One?

Glenmark Pharmaceuticals (GLENMARK) share can be brought through the following modes:
  1. Direct investment: You can buy Glenmark Pharmaceuticals (GLENMARK) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Glenmark Pharmaceuticals (GLENMARK) shares.

What is the main business of Glenmark Pharmaceuticals?

Glenmark Pharmaceuticals Ltd focuses on the discovery and development of new chemical entities (NCEs). It develops and markets branded and generic formulations. The company’s formulation business encompasses therapeutic areas such as dermatology, respiratory, and oncology.

Who are the promoters of Glenmark Pharmaceuticals?

Saldanha Family Trust is the promoter of Glenmark Pharmaceuticals.

What are the Subsidiaries that comes under Glenmark Pharmaceuticals?

Glenmark Holding SA La Chaux-de-Fonds., Glenmark Dominicana SRL., Glenmark Pharmaceuticals Egypt S.A.E., Glenmark Pharmaceuticals Colombia SAS, Colombia., Glenmark Pharmaceuticals FZE., Glenmark Pharmaceuticals (Australia) Pty Ltd., Glenmark Pharmaceuticals Kenya Ltd. are few of the subsidiaries that comes under Glenmark Pharmaceuticals